Schaffner Report: What Adults Should Know about New RSV Vaccines

New vaccines have been licensed in the US to protect adults age 60 years and older from respiratory syncytial virus (RSV). In this episode of the Schaffner Report, William Schaffner, MD, medical director of the National Foundation for Infectious Diseases (NFID) talks with NFID Executive Director and CEO Marla Dalton, CAE, about the new RSV vaccines for adults.
Learn more at: www.nfid.org

[@OmarLocke36]

maybe these should be mandated! make them a requirement for international travel.

[@saraleemacdonald]

Hello! I received my RSV today. My insurance (CenCal) / Medicaid approved it with a prior authorization.

[@snowbird6855]

Condolences

[@annecyle]

Did you have any side effects?

[@saraleemacdonald]

@@annecyle Not really just a sore arm.

[@LLisa180]

Arexvy…not Apexvy

[@daviddoherty4429]

do you get a free gift with every shot

[@NFIDVideos]

The gift of health!

[@gregsutter1805]

​@@NFIDVideosi already have health.

[@Jan96106]

I know you are being facetious, but, yes, you do. If you are at a grocery pharmacy, you get 10 percent off your groceries for every shot.

[@Tamara-id1pe]

@@Jan96106of course you do 😂

[@jb-qi8fz]

A threefer. 2 free donuts if I take 3.